Time adjusted survival curves for high vs. low renalase among patients with COVID-19 disease (using first quartile as cutoff). by Basmah Safdar (12213257)

Cox hazard regression model of renalase and primary composite outcome. by Basmah Safdar (12213257)

Fig 5 - by Pierre Bauvin (18154818)

Means for global competence pre- and post-test scores. by Esther Kim (2996622)

Fig 3 - by Adeel A. Faruki (13839691)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”

<i>rfbV</i> gene triplication in S. Paratyphi A increases VL O-ag production and reduces C3b deposition. by Fermin E. Guerra (6084545)

“…(E) Extracted LPS subjected to gel electrophoresis followed by silver staining showing decreased VL O-ag production in <i>S.</i> Paratyphi A with a single <i>rfbV</i> gene copy compared to wild-type <i>S.…”

Fig 5 - by P. R. Hut (12152350)

Cytosolic mitochondrial DNA release upon MeV and MeV-ΔV infection in culture and in mice. by Pierre Khalfi (7868252)

The dependency of thrombolysis on rt-PA concentration. by Jan Víteček (11434774)

rt-PA-induced lysis of different clot sizes. by Jan Víteček (11434774)

Fig 5 - by Jie He (132999)

Correlation between baseline vitamin D level with socio-demographic factors and clinicopathology characteristics (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Baseline characteristics of study subjects (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Vitamin D concentration changes between baseline and post-chemotherapy in breast cancer patients (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Minimal data set. by Herindita Puspitaningtyas (11618232)

Subjects:

Flowchart of subjects’ inclusion process. by Herindita Puspitaningtyas (11618232)

Subjects:

Mean values of participants’ heart rate. by Ezel Üsten (16548547)

Mean values of participants’ heart rate. by Ezel Üsten (16548547)

Comparison of SF-36 scores of participants with residual limb pain with a VAS score ≥5 and participants with a VAS score <5. by Martin C. Berli (9427264)